Vital Innovations Holdings Limited will hold its 2026 annual general meeting on 29 June 2026 at 11:00 a.m. on the 9/F, Henley Building, 5 Queen’s Road Central, Hong Kong. Shareholders will vote on the following key items:
• 2025 Financial Statements: Presentation of the audited consolidated results and the accompanying directors’ and auditor’s reports for the year ended 31 December 2025.
• Board Composition: – Re-election of executive directors Ms. Rong Xiuli and Mr. Rong Shengli. – Re-election of independent non-executive director Mr. Wong Pong Chun James.
• Remuneration: Authorisation for the board to fix directors’ remuneration.
• Auditor: Re-appointment of Confucius International CPA Limited and authorisation for the board to fix its remuneration.
• Share Issuance Mandate: A general mandate empowering directors to allot, issue, or otherwise deal with additional shares or convertible securities up to 20% of the company’s issued share capital (excluding treasury shares) as at the date of the AGM.
• Share Buy-back Mandate: Authority for the company to repurchase shares on the Stock Exchange or other recognised exchanges up to 10% of issued share capital (excluding treasury shares) during the mandate period.
• Mandate Extension: Conditional extension of the issuance mandate by the aggregate number of shares repurchased under the buy-back mandate, capped at an additional 10% of issued share capital.
Administrative details include proxy submission by 11:00 a.m. on 27 June 2026 and a register-of-members closure from 24 June 2026 to 29 June 2026 (both days inclusive) for voting entitlement purposes. The board currently comprises four executive directors and three independent non-executive directors, with Ms. Rong Xiuli serving as chairperson.
Comments